OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recent updates in urticaria
Ana M. Giménez‐Arnau, Nerea Manzanares, Indrashis Podder
Medicina Clínica (2023) Vol. 161, Iss. 10, pp. 435-444
Closed Access | Times Cited: 6
Ana M. Giménez‐Arnau, Nerea Manzanares, Indrashis Podder
Medicina Clínica (2023) Vol. 161, Iss. 10, pp. 435-444
Closed Access | Times Cited: 6
Showing 6 citing articles:
Comparação da eficácia em longo prazo e da relação custo‐eficácia de omalizumabe nas doses de 150 mg e 300 mg em pacientes com urticária crônica espontânea
Fikriye Kalkan, Sait Yeşillik, Fevzi Demirel, et al.
(2025) Vol. 100, Iss. 1, pp. 31-37
Open Access
Fikriye Kalkan, Sait Yeşillik, Fevzi Demirel, et al.
(2025) Vol. 100, Iss. 1, pp. 31-37
Open Access
Beyond the itch: the complex interplay of immune, neurological, and psychological factors in chronic urticaria
Shurui Yang, Liqiao Chen, Haiming Zhang, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Shurui Yang, Liqiao Chen, Haiming Zhang, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access
Knockdown of miR-155 alleviates skin damage in rats with chronic spontaneous urticaria by modulating the JAK/STAT signaling pathway
Yuepeng An, Yuan Rui, Shanshan Wang, et al.
Allergy Asthma and Clinical Immunology (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Yuepeng An, Yuan Rui, Shanshan Wang, et al.
Allergy Asthma and Clinical Immunology (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 2
Biologic therapy for chronic spontaneous urticaria in pediatrics and adolescents: current landscape, challenges, and future perspectives
Katharina Marlies Duda, Bettina Wedi
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 5, pp. 383-388
Closed Access
Katharina Marlies Duda, Bettina Wedi
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 5, pp. 383-388
Closed Access
Efficacy, safety, and serum cytokine modulation by olopatadine hydrochloride and desloratadine citrate disodium combination therapy in urticaria
Jipeng Xu, Xiao‐Bin Zhang, Qi-Xue Jiang, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 6, pp. 2501-2508
Open Access
Jipeng Xu, Xiao‐Bin Zhang, Qi-Xue Jiang, et al.
American Journal of Translational Research (2024) Vol. 16, Iss. 6, pp. 2501-2508
Open Access
Comparison of long term efficacy and cost-effectiveness of omalizumab in 150 mg and 300 mg doses in patients with chronic spontaneous urticaria
Fikriye Kalkan, Sait Yeşillik, Fevzi Demirel, et al.
Anais Brasileiros de Dermatologia (2024)
Open Access
Fikriye Kalkan, Sait Yeşillik, Fevzi Demirel, et al.
Anais Brasileiros de Dermatologia (2024)
Open Access
